IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 42 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $47,000 | -79.6% | 26,192 | -85.0% | 0.00% | – |
| Q1 2020 | $230,000 | -36.8% | 174,271 | -12.9% | 0.00% | – |
| Q4 2019 | $364,000 | -38.6% | 199,992 | -2.5% | 0.00% | – |
| Q3 2019 | $593,000 | +8.2% | 205,101 | 0.0% | 0.00% | – |
| Q2 2019 | $548,000 | +66.6% | 205,101 | +58.8% | 0.00% | – |
| Q1 2019 | $329,000 | +439.3% | 129,119 | +484.3% | 0.00% | – |
| Q4 2018 | $61,000 | – | 22,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $68,000 | 0.23% |
| Virtu Financial LLC | 325,330 | $390,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 141,000 | $169,000 | 0.02% |
| Clear Creek Financial Management, LLC | 49,696 | $60,000 | 0.01% |
| Palo Alto Investors LP | 77,044 | $92,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 738,620 | $886,000 | 0.00% |
| MARSHALL WACE, LLP | 477,449 | $573,000 | 0.00% |
| WADE G W & INC | 35,000 | $42,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 599,471 | $719,000 | 0.00% |
| BRYN MAWR TRUST Co | 33,892 | $41,000 | 0.00% |